clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2021-99-2-85-90clinmed-190Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESСовременные алгоритмы диагностики и лечения транзиторных ишемических атакModern algorithms for the diagnosis and treatment of transient ischaemic attackshttps://orcid.org/0000-0001-7795-1873ШироковЕ. А.ShirokovE. A.

Широков Евгений Алексеевич — доктор медицинских наук, профессор, профессор кафедры терапии неотложных состояний

107392, Москва

Evgenii A. Shirocon — MD, PhD, DSc, professor, professor of the department of emergency medicine

107392, Moscow

Evg-747747@yandex.ruhttps://orcid.org/0000-0002-2727-4090ГлаткоВ. Л.GlatkoV. L.

107392, Москва

107392, Moscow

https://orcid.org/0000-0002-8717-7372СапроненковаО. А.SapronenkovaO. A.

107392, Москва

107392, Moscow

ФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова» (Московский филиал) Минобороны РоссииРоссияMilitary Medical Academy named after Kirov S.M. (Moscow Branch) of the Ministry of Defense of RussiaRussian Federation2021020720219928590Copyright © Широков Е.А., Глатко В.Л., Сапроненкова О.А., 20212021Широков Е.А., Глатко В.Л., Сапроненкова О.А.Shirokov E.A., Glatko V.L., Sapronenkova O.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/190

Статья посвящена анализу современных тенденций диагностики и лечения транзиторных ишемических атак (ТИА). Распространенность ТИА в популяции не установлена в связи с неопределенностью критериев диагностики. Авторы детально обсуждают проблему качественного диагноза ТИА и, опираясь на действующие клинические рекомендации, рассматривают современные и перспективные методы лечения больных. Особое место авторы уделяют оценке риска кровотечений при проведении агрессивной антитромботической терапии.

The article analyzes the current tendencies in the diagnosis and treatment of transient ischaemic attacks (TIA). The prevalence of TIA in the population has not been established due to the uncertainty of the diagnostic criteria. The authors discuss the problem of a qualitative diagnosis of TIA in detail. Based on the current clinical recommendations, modern and promising methods of treatment are discussed. The authors pay special attention to the assessment of the risk of bleeding during aggressive antithrombotic therapy.

транзиторные ишемические атакикритерии диагностики транзиторных ишемических атакантитромбоцитарная терапия транзиторных ишемических атакtransient ischaemic attackstransient ischaemic attacks diagnostic criteriaantiplatelet therapy of transient ischaemic attacksReferencesAmarenco P., Lavallée C., Monteiro Tavares L. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. New Engl. J. Med. 2018;378(23):2182–2190. Published online 2018 May 16. DOI: 10.1056/NEJMoa1802712Amarenco P., Lavallée C., Monteiro Tavares L. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. New Engl. J. Med. 2018;378(23):2182–2190. Published online 2018 May 16. DOI: 10.1056/NEJMoa1802712Uchiyama S., Amarenco P., Minematsu K. et al. TIA as Acute Cerebrovascular Syndrome. Front. Neurol. Neurosci. Basel, Karger. 2014;33:35–146. DOI: 10.1159/000351914Uchiyama S., Amarenco P., Minematsu K. et al. TIA as Acute Cerebrovascular Syndrome. Front. Neurol. Neurosci. Basel, Karger. 2014;33:35–146. DOI: 10.1159/000351914Shahjouei S., Sadighi A., Chaudhary D. et al. A 5-Decade Analysis of Incidence Trends of Ischemic Stroke After Transient Ischemic Attack. A Systematic Review and Meta-analysis. JAMA Neurol. 2021;78(1):77–87. DOI: 10.1001/jamaneurol.2020.3627Shahjouei S., Sadighi A., Chaudhary D. et al. A 5-Decade Analysis of Incidence Trends of Ischemic Stroke After Transient Ischemic Attack. A Systematic Review and Meta-analysis. JAMA Neurol. 2021;78(1):77–87. DOI: 10.1001/jamaneurol.2020.3627Dolmans L.S., Hoes A., Bartelink E. et al. Patient delay in TIA: a systematic review. Jornal of Neurology. 2019;266(5):1051–1058. DOI: 10.1007/s00415-018-8977-6Dolmans L.S., Hoes A., Bartelink E. et al. Patient delay in TIA: a systematic review. Jornal of Neurology. 2019;266(5):1051–1058. DOI: 10.1007/s00415-018-8977-6Лебедева Е.Р., Гурарий Н.М., Олесен Е. Диагностические критерии транзиторной ишемической атаки. Неврология, нейропсихиатрия, психосоматика. 2018;10(2):12–19.Lebedeva E.R., Gurary N.M., Olesen E. Diagnostic criteria for transient ischemic attack. Neurology, neuropsychiatry, psychosomatics. 2018;10(2):12– 19. (in Russian)Paul N., Rothwell P. Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study. Lancet Neurol. 2013;12:65–71.Paul N., Rothwell P. Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study. Lancet Neurol. 2013;12:65–71.Stroke foundation of New Zealand. New Zealand guideline for the assessment and management of people with recent transient ischaemic attack (TIA). 2008. [Electronic resource]. URL: www.stroke.org.nz (accessed 2011 May 3).Stroke foundation of New Zealand. New Zealand guideline for the assessment and management of people with recent transient ischaemic attack (TIA). 2008. [Electronic resource]. URL: www.stroke.org.nz (accessed 2011 May 3).The Stroke Prevention and Educational Awareness Diff usion (SPREAD) Collaboration. The Italian guidelines for stroke prevention. Neurol. Sci. 2006;21:5–12.The Stroke Prevention and Educational Awareness Diff usion (SPREAD) Collaboration. The Italian guidelines for stroke prevention. Neurol. Sci. 2006;21:5–12.Special report from the National Institute of Neurological Disorders and Stroke. Classifi cation of cerebrovascular diseases III. Stroke. 1990;21(4):637–76. DOI: 10.1161/01.str.21.4.637Special report from the National Institute of Neurological Disorders and Stroke. Classifi cation of cerebrovascular diseases III. Stroke. 1990;21(4):637–76. DOI: 10.1161/01.str.21.4.637Широков Е.А., Симоненко В.Б., Овчинников Ю.В. Транзиторные ишемические атаки и малые инсульты: современные терапевтические стратегии. Лечащий врач. 2020;5:7–11.Shirokov E.A., Simonenko V.B., Ovchinnikov Yu.V. Transient ischemic attacks and small strokes: modern therapeutic strategies. Lechasyi vrach. 2020; 5:7–11. (in Russian)Lioutas V., Ivan C., Himali J. et al. Incidence of Transient Ischemic Attack and Association With Long-term Risk of Stroke. JAMA. 2021;325(4):373–381. DOI:10.1001/jama.2020.25071Lioutas V., Ivan C., Himali J. et al. Incidence of Transient Ischemic Attack and Association With Long-term Risk of Stroke. JAMA. 2021;325(4):373–381. DOI:10.1001/jama.2020.25071Powers W., Rabinstein A., Ackerson T. et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3): e46-e110. DOI: 10.1161/STR.0000000000000158Powers W., Rabinstein A., Ackerson T. et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3): e46-e110. DOI: 10.1161/STR.0000000000000158Prasad K., Siemieniuk R., Hao Q. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. BMJ. 2018;363:k5130. DOI: 10.1136/bmj.k5130Prasad K., Siemieniuk R., Hao Q. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. BMJ. 2018;363:k5130. DOI: 10.1136/bmj.k5130Sandercock P., Counsell C., Tseng M.C., Cecconi E. Oral antiplatelet therapy for acute ischemic stroke. Cochrane Database of Systematic Reviews. 2014;2014(3):CD000029. DOI: 10.1002/14651858.CD000029.pub3Sandercock P., Counsell C., Tseng M.C., Cecconi E. Oral antiplatelet therapy for acute ischemic stroke. Cochrane Database of Systematic Reviews. 2014;2014(3):CD000029. DOI: 10.1002/14651858.CD000029.pub3Li Z., Wang Y., Zhao X. et al. Treatment eff ect of clopidogrel plus aspirin within 12 hours of acute minor stroke or transient ischemic attack. J. Am. Heart. Assoc. 2016;5(3):e003038. DOI: 10/1161/JAHA.115.003038Li Z., Wang Y., Zhao X. et al. Treatment eff ect of clopidogrel plus aspirin within 12 hours of acute minor stroke or transient ischemic attack. J. Am. Heart. Assoc. 2016;5(3):e003038. DOI: 10/1161/JAHA.115.003038Pan Y. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack. JAMA Neurol. 2019;76(12): 1466–1473. Published online 2019 August 19. DOI: 10.1001/jamaneurol.2019.2531Pan Y. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack. JAMA Neurol. 2019;76(12): 1466–1473. Published online 2019 August 19. DOI: 10.1001/jamaneurol.2019.2531Dutta D. Diagnosis of TIA (DOT) score — design and validation of a new clinical diagnostic tool for transient ischaemic attack. BMC Neurology. 2016;16:20. DOI: 10.1186/s12883-016-0535-1Dutta D. Diagnosis of TIA (DOT) score — design and validation of a new clinical diagnostic tool for transient ischaemic attack. BMC Neurology. 2016;16:20. DOI: 10.1186/s12883-016-0535-1Giles M.F., Albers G.W., Amarenco P. et al. Early stroke risk and ABCD2 score performance in tissue- vs time-defi ned TIA: a multicenter study. Neurology. 2011;77:1222–8.Giles M.F., Albers G.W., Amarenco P. et al. Early stroke risk and ABCD2 score performance in tissue- vs time-defi ned TIA: a multicenter study. Neurology. 2011;77:1222–8.Amarenco P., Labreuche J., Lavallée P.C. Patients with transient ischemic attack with ABCD2 <4 can have similar 90-day stroke risk as patients with transient ischemic attack with ABCD2 ≥4. Stroke. 2012;43:863–5.Amarenco P., Labreuche J., Lavallée P.C. Patients with transient ischemic attack with ABCD2 <4 can have similar 90-day stroke risk as patients with transient ischemic attack with ABCD2 ≥4. Stroke. 2012;43:863–5.Буряковская Л.И., Ломакин Н.В., Сумароков А.Б., Широков Е.А. Эффективность и безопасность антитромботической терапии. Шкалы и алгоритмы. Клинические рекомендации для врачей. М.: НОВ, 2019:170.Buryakovskaya L.I., Lomakin N.V., Sumarokov A.B., Shirokov E.A. Effi ciency and safety of antithrombotic therapy. Scales and algorithms. Clinical recommendations for doctors. Moscow; NOB, 2019:170. (in Russian)Uchiyama S. TIA as Acute Cerebrovascular Syndrome. J. Neurol. Disord. Stroke. 2017;5(1):1121–8.Uchiyama S. TIA as Acute Cerebrovascular Syndrome. J. Neurol. Disord. Stroke. 2017;5(1):1121–8.Симоненко В.Б., Широков Е.А., Фролов В.М. Клиническая кризология в кардионеврологии. Руководство для врачей. М.; КВОРУМ, 2013:291.Simonenko V.B., Shirokov E.A., Frolov V.M. Clinical crizology in cardioneurology. Manual for doctors. Moscow; QUORUM, 2013:291. (in Russian)The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA. 1998;279:1265–1272.The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA. 1998;279:1265–1272.Martinez-Majander N., Ntaios G., LiuI Y.Y. et al. Rivaroxaban versus aspirin for secondary prevention of ischemic stroke in patients with cancer: a subgroup analysis of NAVIGATE ESUS randomized trial. Eur. J. Neurol. 2020;27(5):841–848. DOI: 10.1111/ene.14172. Published online 2020.Martinez-Majander N., Ntaios G., LiuI Y.Y. et al. Rivaroxaban versus aspirin for secondary prevention of ischemic stroke in patients with cancer: a subgroup analysis of NAVIGATE ESUS randomized trial. Eur. J. Neurol. 2020;27(5):841–848. DOI: 10.1111/ene.14172. Published online 2020.Huisa B.N., Raman R., Ernstrom K. et al. Alberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke. J. Stroke Cerbrovasc. Dis. 2010;19:475–479. DOI: 10/1016/j.jstrokecerebrovasdis.2010.03.003Huisa B.N., Raman R., Ernstrom K. et al. Alberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke. J. Stroke Cerbrovasc. Dis. 2010;19:475–479. DOI: 10/1016/j.jstrokecerebrovasdis.2010.03.003Широков Е.А. COVID-ассоциированный ишемический инсульт. Клиническая медицина. 2020;98(5):375–377.Shirokov E.A. COVID-associated ischemic stroke. Klinicheskaja medicina. 2020; 98(5):375–377. (in Russian)Chen Z.M., Sandercoch P., Pan H.C. et al. Indication for early aspirin use in acute ischemic stroke. A combined analysis of 40 000 randomized patients from the Chines Acute Stroke Trial and the International Stroke Trial. Stroke. 2000;31:1240–1249.Chen Z.M., Sandercoch P., Pan H.C. et al. Indication for early aspirin use in acute ischemic stroke. A combined analysis of 40 000 randomized patients from the Chines Acute Stroke Trial and the International Stroke Trial. Stroke. 2000;31:1240–1249.Lavallée P., Amarenco P. Stroke Subtypes and Interventional Studies for Transient Ischemic Attack. TIA as Acute Cerebrovascular Syndrome. Front. Neurol. Neurosci. Basel, Karger. 2014;33:135– 146. DOI: 10.1159/000351914Lavallée P., Amarenco P. Stroke Subtypes and Interventional Studies for Transient Ischemic Attack. TIA as Acute Cerebrovascular Syndrome. Front. Neurol. Neurosci. Basel, Karger. 2014;33:135– 146. DOI: 10.1159/000351914Kennedy J., Ryckborst K. et al. for the FASTER investigators: Fast Assessment of Stroke and Transient Ischemic Attack to prevent Early Recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol. 2007;6:961–969.Kennedy J., Ryckborst K. et al. for the FASTER investigators: Fast Assessment of Stroke and Transient Ischemic Attack to prevent Early Recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol. 2007;6:961–969.2020 ESC Guidelines for the diagnosis and management of atrial fi brillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2021;42(5):373–498. DOI: 10.1093/eurheartj/ehaa6122020 ESC Guidelines for the diagnosis and management of atrial fi brillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2021;42(5):373–498. DOI: 10.1093/eurheartj/ehaa612Amarenco P. Transient Ischemic Attack. N. Engl. J. Med. 2020;382:1933–41. DOI: 10.1056/NEJMcp1908837Amarenco P. Transient Ischemic Attack. N. Engl. J. Med. 2020;382:1933–41. DOI: 10.1056/NEJMcp1908837Pan Y., Elm J., Li H. et al. Outcomes Associated With ClopidogrelAspirin Use in Minor Stroke or Transient Ischemic Attack. A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and PlateletOriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. JAMA Neurol. 2019;76(12):1466–1473. DOI: 10.1001/jamaneurol.2019.2531Pan Y., Elm J., Li H. et al. Outcomes Associated With ClopidogrelAspirin Use in Minor Stroke or Transient Ischemic Attack. A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and PlateletOriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. JAMA Neurol. 2019;76(12):1466–1473. DOI: 10.1001/jamaneurol.2019.2531Johnston S., Amarenco P., M.D., Denison H. et al. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. N. Engl. J. Med. 2020;383:207–17. DOI: 10.1056/NEJMoa1916870Johnston S., Amarenco P., M.D., Denison H. et al. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. N. Engl. J. Med. 2020;383:207–17. DOI: 10.1056/NEJMoa1916870

The authors declare that there are no conflicts of interest present.